Camlin Fine Sciences Limited

NSE CAMLINFINE.NS

Camlin Fine Sciences Limited Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -7.97 M

Camlin Fine Sciences Limited Net Cash Used For Investing Activities is USD -7.97 M for the year ending March 31, 2024, a 47.42% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Camlin Fine Sciences Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -15.16 M, a 53.78% change year over year.
  • Camlin Fine Sciences Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -32.81 M, a -80.83% change year over year.
  • Camlin Fine Sciences Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -18.14 M, a -51.72% change year over year.
  • Camlin Fine Sciences Limited Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -11.96 M, a -4,187.22% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
NSE: CAMLINFINE.NS

Camlin Fine Sciences Limited

CEO Mr. Ashish Subhash Dandekar
IPO Date Jan. 20, 2015
Location India
Headquarters Building in G. S. Point, Plot No. VIII
Employees 624
Sector Consumers Staples
Industries
Description

Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.

Similar companies

FCL.NS

Fineotex Chemical Limited

USD 3.74

-0.16%

SHK.NS

S H Kelkar and Company Limited

USD 2.47

1.26%

SUDARSCHEM.NS

Sudarshan Chemical Industries Limited

USD 11.52

-5.12%

BODALCHEM.NS

Bodal Chemicals Limited

USD 0.72

2.30%

TIRUMALCHM.NS

Thirumalai Chemicals Limited

USD 2.75

-0.82%

StockViz Staff

February 2, 2025

Any question? Send us an email